Influence of activated charcoal on the pharmacokinetics and the clinical features of carbamazepine poisoning
Authors:
- Nozha BrahmiNBNozha Brahmi
- Nadia KouraichiNKNadia Kouraichi
- Hafedh ThabetHTHafedh Thabet
- Mouldi AmamouMAMouldi Amamou
- 1 July 2006
- journal article
- research article
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 24 (4) , 440-443
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Pediatric Carbamazepine Suspension Overdose-Clinical Manifestations and ToxicokineticsPediatric Emergency Care, 2005
- Management of a Severe Carbamazepine Overdose Using Albumin-Enhanced Continuous Venovenous HemodialysisPediatrics, 2004
- Carbamazepine Poisoning: Elimination Kinetics and Quantitative Relationship with Carbamazepine 10,11-EpoxideJournal of Toxicology: Clinical Toxicology, 2002
- Position Statement and Practice Guidelines on the Use of Multi-Dose Activated Charcoal in the Treatment of Acute PoisoningJournal of Toxicology: Clinical Toxicology, 1999
- Treatment of acute carbamazepine poisoning by hemoperfusionThe American Journal of Emergency Medicine, 1996
- Carbamazepine Overdose - The Effects of Multiple dose Activated CharcoalJournal of Toxicology: Clinical Toxicology, 1992
- ACTIVATED CHARCOAL FOR CARBAMAZEPINE POISONINGThe Lancet, 1987
- Clinical Pharmacokinetics of Carbamazepine and its Epoxy and Hydroxy Metabolites in Humans After an OverdoseTherapeutic Drug Monitoring, 1986
- Clinical Pharmacokinetics and Pharmacological Effects of Carbamazepine and Carbamazepine-10,11-EpoxideClinical Pharmacokinetics, 1986
- Pharmacokinetic Aspects of Carbamazepine and its two Major Metabolites in Plasma During OverdosageHuman Toxicology, 1983